|
|
 |
您現(xiàn)在的位置:產(chǎn)品中心 >>
分子生化試劑 >> 生化試劑 |
正品|ACETYL-11-KETO-B-BOSWELLIC ACID
產(chǎn)品編號: |
110123-5MG
查看說明書 |
產(chǎn)品名稱:
|
正品|ACETYL-11-KETO-B-BOSWELLIC ACID .0 訂購此產(chǎn)品 |
供應(yīng)商:
|
Merck |
規(guī)格: |
5MG |
目錄價: |
2,504.00 |
庫存狀態(tài): |
3周到貨 |
CAS編號:
|
67416-61-9 |
應(yīng)用范圍: |
生化實驗 |
種屬來源: |
|
相關(guān)信息: |
|
正品|ACETYL-11-KETO-B-BOSWELLIC ACID
產(chǎn)品信息
Form White solid
Primary Target 5-lipoxygenase
Primary Target IC50 1.5 µM in rat PMNLs
Protect from Light 是的
Packaged under inert gas 是的
Cell permeable 是的
Purity ≥98% by HPLC
Chemical formula C32H48O5
CAS number 67416-61-9
Storage +2°C to +8°C
Ship Ambient Temperature Only
Carcinogenic / Teratogenic
產(chǎn)品說明
A cell-permeable pentacyclic triterpene of the ursane type that displays anti-tumor and anti-inflammatory properties. Shown to block the phosphorylation and degradation of IκBα and inhibit NF-κB-mediated gene transcription in chemoresistant, androgen-independent PC-3 prostate cancer cells (~10 µM). Mobilizes intracellular Ca2+ and stimulates the activation of p42/44 and p38 MAPKs (~30 µM in human PMN) and increases the formation of reactive oxygen species. Also reported to induce apoptosis and act as a non-redox, non-competitive inhibitor of 5-lipoxygenase (IC50 = 1.5 µM in rat PMNLs), and topoisomerase I (≥ 10 µM in calf thymus). When complexed with γ-cyclodextrin to facilitate its delivery, AKβBA has been demonstrated to exhibit in vivo efficacy in tumor growth and inhibition. |
保存條件: |
2°C to 8°C |
說明書地址: |
點擊查看詳細(xì) |
|
|
打印此頁 關(guān)閉此頁 |
上一個:B1-2,3,4,6-N-AC-GLUCOSAMINIDASE, RECOM[110116-1U/***]
下一個:N-ACETYLNEURAMINIC ACID, SYNTHETIC[110138-1GM/***]
|
|
 |
 |
|